Sponsored by: West Pharmaceuticals
Since FDA introduced the term to the pharmaceutical industry in 2005, the concept of pharmaceutical quality by design (pharma QbD), a framework for building quality into pharmaceuticals during drug development has been slowly gaining ground. Discrete industries are no strangers to QbD. Now, however, some vendors to the pharmaceutical industries are applying pharma QbD principles to develop their pharmaceutical industry products. This e-book offers general resources in the area of QbD, and discusses how West Pharmaceuticals has been bringing a QbD approach to its packaging components. Read Now.
Related posts:
- Holistic Quality and Compliance: A Guide For, and From, the C-Level, by John Avellanet
- In a world full of dull Lean Six Sigma books, written by those distanced from C-level pharma experience, there's a...
- QbD for Pharma Packaging Components: A Solution Provider Gets More Science-Based
- Putting itself in the shoes of its customers, West Pharmaceutical Services aims to leverage Quality by Design to improve its...
- FDA Publishes Long-Awaited Process Validation Guidance
- The Agency's new document provides a much-needed update to its 1987 guidelines....
- The Next Generation Approach to Sterile Products and Total Cost of Ownership
- The adoption of QbD by industry suppliers is the future, says West Pharma's Fran DeGrazio. Here, she provides an overview...
- Peeling Back the Layers: FDA Posts Case Study on Modified Release Dosages
- The document is daunting (159 pages) but wonderfully detailed and descriptive....
